Company Directory > CRO > Meclinas

Meclinas

Mechelen, Belgium
VISIT WEBSITE
Meclinas is a boutique Clinical Research Organization (CRO) based in Mechelen, Belgium, specializing in the management and monitoring of clinical trials across the Benelux region. The company provides high-touch services for pharmaceutical, biotechnology, and medical device companies, focusing on quality, flexibility, and local regulatory expertise. The firm offers a comprehensive suite of services including site selection, project management, clinical monitoring (Phase I-IV), and regulatory affairs. By maintaining a lean and specialized team, Meclinas positions itself as a strategic partner for small-to-mid-sized biotech firms that require deep local knowledge of the Belgian and Dutch clinical trial ecosystems.
CLASSIFICATION
Company Type:CRO
Industry:Pharmaceuticals
Sub-Industry:CRO (Clinical Research Organization)
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2013
Ownership:private
Status:operating
FUNDING
Stage:Self-funded / Profitable
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Biologics, Medical Devices
Active Trials:12
Trial Phases:Phase 1: 2 | Phase 2: 4 | Phase 3: 5 | Phase 4: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Local Belgian Hospitals (UZ Leuven, UZA), European Biotech SME Network
COMPETITION
Position:Niche Player
Competitors:SGS Health Science, Venn Life Sciences, Avania, PPD (Thermo Fisher), IQVIA
LEADERSHIP
Key Executives:
Koenraad Mertens - Managing Director
Scientific Founders:Koenraad Mertens
LINKS
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Meclinas and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Meclinas. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.